Sales Agreements in the Biotechnology Industry

453 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
4D Molecular Therapeutics Inc (1)
89bio, Inc. (1)
Acorda Therapeutics (1)
Actinium Pharmaceuticals, Inc. (3)
Acumen Pharmaceuticals, Inc. (1)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (1)
Adverum Biotechnologies, Inc. (1)
Aeglea BioTherapeutics, Inc. (2)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (1)
AILERON THERAPEUTICS INC (1)
Akebia Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Alector, Inc. (1)
Alexion Pharmaceuticals (1)
Allakos Inc. (4)
Allarity Therapeutics, Inc. (2)
Allena Pharmaceuticals, Inc. (2)
Allogene Therapeutics, Inc. (1)
ALPINE IMMUNE SCIENCES, INC. (1)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (2)
Amplitude Healthcare Acquisition Corp (1)
ANAVEX LIFE SCIENCES CORP. (2)
Annexon, Inc. (1)
Annovis Bio, Inc. (1)
Apellis Pharmaceuticals, Inc. (1)
Applied Molecular Transport Inc. (1)
Applied Therapeutics Inc. (1)
Aptinyx Inc. (1)
Aptose Biosciences Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (10)
Arcturus Therapeutics Holdings Inc. (2)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (3)
Aridis Pharmaceuticals, Inc. (1)
ASSEMBLY BIOSCIENCES, INC. (1)
Atara Biotherapeutics, Inc. (5)
Athenex, Inc. (1)
AVEO PHARMACEUTICALS INC (2)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (2)
Axovant Sciences Ltd. (3)
Beam Therapeutics Inc. (3)
Benitec Biopharma Inc. (1)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (1)
BioCardia, Inc. (1)
BIOCEPT INC (1)
BIOMARIN PHARMACEUTICAL INC (1)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
bluebird bio, Inc. (1)
Blueprint Medicines Corp (2)
Calithera Biosciences, Inc. (2)
CareDx, Inc. (1)
CATABASIS PHARMACEUTICALS INC (2)
Celcuity Inc. (1)
Celldex Therapeutics, Inc. (2)
Celsion CORP (1)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (2)
Codiak BioSciences, Inc. (1)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (3)
Conatus Pharmaceuticals Inc. (2)
Constellation Alpha Capital Corp. (1)
Corvus Pharmaceuticals, Inc. (3)
Crinetics Pharmaceuticals, Inc. (1)
CTI BIOPHARMA CORP (1)
Cue Biopharma, Inc. (4)
CURIS INC (1)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (1)
Cytokinetics, Incorporated (2)
CYTORI THERAPEUTICS, INC. (1)
DBV Technologies S.A. (1)
DelMar Pharmaceuticals, Inc. (1)
Denali Therapeutics Inc. (9)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (1)
DYNAVAX TECHNOLOGIES CORP (2)
Edge Therapeutics, Inc. (1)
Editas Medicine, Inc. (1)
Entasis Therapeutics Holdings Inc. (1)
Entera Bio Ltd. (2)
Entrada Therapeutics, Inc. (1)
Esperion Therapeutics, Inc. (1)
Evelo Biosciences, Inc. (1)
FATE THERAPEUTICS INC (1)
FIVE PRIME THERAPEUTICS INC (1)
Foghorn Therapeutics Inc. (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (4)
FS Development Corp. (2)
G1 Therapeutics, Inc. (1)
GENEREX BIOTECHNOLOGY CORP (1)
GeoVax Labs, Inc. (1)
GERON CORP (3)
GLYCOMIMETICS INC (2)
GTX INC (1)
GX Acquisition Corp. (1)
HEAT BIOLOGICS, INC. (7)
HEMISPHERX BIOPHARMA INC (3)
HISTOGENICS CORP (4)
HUMANIGEN, INC (1)
IDEAYA Biosciences, Inc. (2)
IDERA PHARMACEUTICALS, INC. (2)
Immix Biopharma, Inc. (2)
Immunome Inc. (1)
IMMUNOMEDICS INC (1)
INFINITY PHARMACEUTICALS, INC. (3)
Inmune Bio, Inc. (5)
INOVIO PHARMACEUTICALS, INC. (6)
INSMED Inc (2)
Intec Pharma Ltd. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
INTREXON CORP (1)
Invitae Corp (3)
IO Biotech, Inc. (1)
Isoray, Inc. (2)
Jounce Therapeutics, Inc. (2)
KalVista Pharmaceuticals, Inc. (1)
Karyopharm Therapeutics Inc. (2)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (1)
Krystal Biotech, Inc. (3)
Kura Oncology, Inc. (5)
LEAP THERAPEUTICS, INC. (1)
LifeSci Acquisition Corp. (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
MACROGENICS INC (2)
MADRIGAL PHARMACEUTICALS, INC. (6)
MAIA Biotechnology, Inc. (1)
MANNKIND CORP (1)
MEDICINOVA INC (2)
MEI Pharma, Inc. (3)
Mersana Therapeutics, Inc. (3)
Millendo Therapeutics, Inc. (1)
Mirati Therapeutics, Inc. (1)
Mirum Pharmaceuticals, Inc. (1)
Moderna, Inc. (1)
Molecular Templates, Inc. (3)
Moleculin Biotech, Inc. (3)
Monopar Therapeutics (1)
MUSTANG BIO, INC. (5)
Myovant Sciences Ltd. (1)
NANOVIRICIDES, INC. (2)
NantKwest, Inc. (1)
NEWLINK GENETICS CORP (1)
NexImmune, Inc. (1)
NextCure, Inc. (1)
NOVAVAX INC (12)
Novus Therapeutics, Inc. (1)
Nuvalent, Inc. (1)
Olema Pharmaceuticals, Inc. (2)
OncoCyte Corp (2)
ONCOSEC MEDICAL Inc (1)
ORAGENICS INC (3)
Orchard Therapeutics plc (1)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (1)
Outlook Therapeutics, Inc. (1)
PepGen Inc. (1)
Pfenex Inc. (2)
PIERIS PHARMACEUTICALS, INC. (1)
PLURISTEM THERAPEUTICS INC (1)
POLARITYTE, INC. (1)
PROGENITY, INC. (1)
Protagenic Therapeutics, Inc. (2)
Protalix BioTherapeutics, Inc. (1)
PROTEOSTASIS THERAPEUTICS, INC. (2)
PTC THERAPEUTICS, INC. (1)
Radius Health, Inc. (5)
RECURSION PHARMACEUTICALS, INC. (1)
REGENXBIO Inc. (2)
Reneo Pharmaceuticals, Inc. (1)
Repare Therapeutics Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (3)
REXAHN PHARMACEUTICALS, INC. (3)
RHYTHM PHARMACEUTICALS, INC. (1)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (2)
Savara Inc (1)
SELECTA BIOSCIENCES INC (1)
Seres Therapeutics, Inc. (3)
Shattuck Labs, Inc. (1)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (1)
SOLIGENIX, INC. (3)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (4)
Spectrum Pharmaceuticals, Inc. (14)
Spero Therapeutics, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
Sun BioPharma, Inc. (1)
SUNESIS PHARMACEUTICALS INC (3)
Surface Oncology, Inc. (2)
Syndax Pharmaceuticals Inc (1)
SYNLOGIC, INC. (1)
Synthetic Biologics, Inc. (5)
T2 Biosystems, Inc. (1)
Taysha Gene Therapies, Inc. (1)
TENAX THERAPEUTICS, INC. (1)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (1)
Tocagen Inc (2)
Tonix Pharmaceuticals Holding Corp. (2)
Tracon Pharmaceuticals, Inc. (2)
TScan Therapeutics, Inc. (1)
Twist Bioscience Corp (1)
Ultragenyx Pharmaceutical Inc. (2)
uniQure N.V. (3)
Unity Biotechnology, Inc. (3)
UroGen Pharma Ltd. (1)
Vaxart, Inc. (1)
Vaxcyte, Inc. (1)
Verastem, Inc. (1)
Vericel Corp (1)
VICAL INC (1)
Viking Therapeutics, Inc. (2)
Virios Therapeutics, LLC (1)
VITAL THERAPIES INC (3)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (1)
vTv Therapeutics Inc. (2)
WINDTREE THERAPEUTICS INC (2)
XBiotech Inc. (1)
Xencor Inc (1)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (5)
XOMA Corp (3)
ZAFGEN, INC. (2)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Sales Agreement, dated February 3, 2025, among Aptose Biosciences Inc. and A.G.P./Alliance Global Partners

Sales Agreements

Aptose Biosciences Inc.

Biotechnology

2025

Sales Agreement dated January 21, 2025 between Vincerx Pharma, Inc. and H.C. Wainwright & Co., LLC

Sales Agreements

LifeSci Acquisition Corp.

Biotechnology

2025

Sales Agreement, dated January 13, 2025, between the Company and Leerink Partners LLC

Sales Agreements

REXAHN PHARMACEUTICALS, INC.

Biotechnology

2025

Amendment No. 1 to At Market Issuance Sales Agreement, dated as of January 9, 2025, by and between Protagenic Therapeutics, Inc. and B. Riley Securities, Inc

Sales Agreements

Protagenic Therapeutics, Inc.

Biotechnology

2025

At-the-Market Sales Agreement dated as of January 6, 2025 between Lixte Biotechnology Holdings, Inc. and WallachBeth Capital, LLC

Sales Agreements

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Biotechnology

2025

Sales Agreement, dated as of December 9, 2024, between Leerink Partners LLC and REGENXBIO Inc

Sales Agreements

REGENXBIO Inc.

Biotechnology

2024

Controlled Equity OfferingSM Sales Agreement dated November 15, 2024 by and between Disc Medicine, Inc. and Cantor Fitzgerald & Co

Sales Agreements

FS Development Corp.

Biotechnology

2024

Common Shares Sales Agreement, dated November 4, 2024, by and between Repare Therapeutics Inc. and TD Securities (USA) LLC

Sales Agreements

Repare Therapeutics Inc.

Biotechnology

2024

REVOLUTION MEDICINES, INC. $500,000,000 SALES AGREEMENT

Sales Agreements

Revolution Medicines, Inc.

Biotechnology

2024

Sales Agreement dated, October 11, 2024, between Oragenics, Inc. and Dawson James Securities, Inc

Sales Agreements

ORAGENICS INC

Biotechnology

2024

Sales Agreement, dated as of October 11, 2024, between Benitec Biopharma Inc. and Leerink Partners LLC

Sales Agreements

Benitec Biopharma Inc.

Biotechnology

2024

At-The-Market Issuance Sales Agreement, dated October 3, 2024, with Ascendiant Capital Markets, LLC

Sales Agreements

Alzamend Neuro, Inc.

Biotechnology

2024

Sales Agreement, by and between the Company and A.G.P./Alliance Global Partners, dated September 25, 2024

Sales Agreements

GeoVax Labs, Inc.

Biotechnology

2024

Second Amendment to At-The-Market Issuance Sales Agreement, dated September 9, 2024

Sales Agreements

Allarity Therapeutics, Inc.

Biotechnology

2024

At Market Issuance Sales Agreement dated August 16, 2024 between Soligenix, Inc. and A.G.P./Alliance Global Partners

Sales Agreements

SOLIGENIX, INC.

Biotechnology

2024

Controlled Equity OfferingSM Sales Agreement, dated as of August 13, 2024, by and among Perspective Therapeutics, Inc., Cantor Fitzgerald & Co. and RBC Capital Markets, LLC

Sales Agreements

Isoray, Inc.

Biotechnology

2024

Amended and Restated At Market Issuance Sales Agreement dated August 13, 2024 by and between the Company, B. Riley Securities, Inc., and H.C. Wainwright & Co., LLC

Sales Agreements

Edge Therapeutics, Inc.

Biotechnology

2024

At-the-Market Sales Agreement, dated August 9, 2024, by and among INmune Bio Inc., RBC Capital Markets, LLC and BTIG, LLC

Sales Agreements

Inmune Bio, Inc.

Biotechnology

2024

Sales Agreement, dated August 9, 2024, by and between the Oncocyte Corporation and Needham & Company, LLC

Sales Agreements

OncoCyte Corp

Biotechnology

2024

At-The-Market Issuance Sales Agreement between the Company and Ascendiant Capital Markets, LLC dated August 8, 2024

Sales Agreements

ORAGENICS INC

Biotechnology

2024

Sales Agreement, dated as of August 7, 2024, by and between Revolution Medicines, Inc. and TD Securities (USA), LLC

Sales Agreements

Revolution Medicines, Inc.

Biotechnology

2024

Sales Agreement, dated July 30, 2024, by and between Tonix Pharmaceuticals Holdings Corp. and A.G.P./Alliance Global Partners

Sales Agreements

Tonix Pharmaceuticals Holding Corp.

Biotechnology

2024

Sales Agreement, dated June 21, 2024, by and among Crinetics Pharmaceuticals, Inc., Leerink Partners LLC and Cantor Fitzgerald & Co

Sales Agreements

Crinetics Pharmaceuticals, Inc.

Biotechnology

2024

Sales Agreement, dated May 3, 2021, by and between the Registrant and Leerink Partners (formerly SVB Leerink LLC)

Sales Agreements

Keros Therapeutics, Inc.

Biotechnology

2024

Sales Agreement, dated June 7, 2024, by and between the Company and Leerink Partners LLC

Sales Agreements

4D Molecular Therapeutics Inc

Biotechnology

2024

Sales Agreement, by and between Immunome, Inc. and TD Securities (USA) LLC, dated May 14, 2024

Sales Agreements

Immunome Inc.

Biotechnology

2024

Sales Agreement, dated as of May 9, 2024, by and between the Company and Guggenheim Securities, LLC

Sales Agreements

ZAFGEN, INC.

Biotechnology

2024

Sales Agreement, dated May 7, 2024, by and between Madrigal Pharmaceuticals, Inc. and TD Securities (USA) LLC

Sales Agreements

MADRIGAL PHARMACEUTICALS, INC.

Biotechnology

2024

Amendment No. 2 to the Amended and Restated At Market Issuance Sales Agreement, dated May 2, 2024 by and between Theriva Bilogics, Inc. and and A.G.P./Alliance Global Partners

Sales Agreements

Synthetic Biologics, Inc.

Biotechnology

2024

Amendment No. 1 to Sales Agreement, dated as of May 1, 2024, between Corvus Pharmaceutical, Inc. and Jefferies LLC

Sales Agreements

Corvus Pharmaceuticals, Inc.

Biotechnology

2024

Amendment, dated April 12, 2024, to Sales Agreement, dated May 16, 2023, by and between the Company and BTIG

Sales Agreements

Outlook Therapeutics, Inc.

Biotechnology

2024

At Market Issuance Sales Agreement by and between NanoViricides, Inc. and EF Hutton LLC

Sales Agreements

NANOVIRICIDES, INC.

Biotechnology

2024

Sales Agreement, dated March 22, 2024, by and between Lineage Cell Therapeutics, Inc. and B. Riley Securities, Inc

Sales Agreements

BIOTIME INC

Biotechnology

2024

At-The-Market Issuance Sales Agreement, dated March 19, 2024, by and between Allarity Therapeutics, Inc. and Ascendiant Capital Markets, LLC

Sales Agreements

Allarity Therapeutics, Inc.

Biotechnology

2024

Amended and Restated Sales Agreement, dated March 13, 2024, by and between the Company and Jefferies LLC

Sales Agreements

Solid Biosciences Inc.

Biotechnology

2024

Amendment No. 1 to Sales Agreement, dated as of February 29, 2024, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC

Sales Agreements

RHYTHM PHARMACEUTICALS, INC.

Biotechnology

2024

Sales Agreement, dated February 28, 2024, by and between vTv Therapeutics Inc. and Cowen and Company, LLC

Sales Agreements

vTv Therapeutics Inc.

Biotechnology

2024

Sales Agreement, dated February 28, 2024, by and between the Company and Cowen and Company, LLC

Sales Agreements

Mersana Therapeutics, Inc.

Biotechnology

2024

Sales Agreement, dated February 27, 2024, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC

Sales Agreements

SpringWorks Therapeutics, Inc.

Biotechnology

2024

Sales Agreement, dated February 26, 2024, by and between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co

Sales Agreements

Celldex Therapeutics, Inc.

Biotechnology

2024

Category

Industry

Companies

Contracts

Sales Agreements in the Biotechnology Industry